Key facts
- Notable investors include Lion X Ventures, Honsun (Nantong).
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Enmedi
- ·The full record, as it builds
Funding rounds
No funding rounds for Enmedi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enmedi
Developer of artificial intelligence-powered medical devices designed to enable early detection and screening of cardiopulmonary diseases. The company offers AI-assisted auscultation technology, clinical-grade electronic stethoscopes, and advanced diagnostic sound recognition models, enabling hospitals, clinics, and healthcare providers to improve diagnostic accuracy and support timely patient care.
- Sector
- Healthcare
- HQ
- Huzhou, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Enmedi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enmedi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enmedi in its N-PORT filings yet. We sweep new filings monthly.